FOXM1 and cervical cancer: A prior study has also shown that miR-216b can inhibit the proliferation of cervical cancer cells by targeting FOXM1, and miR-216b can further down-regulate FOXM1 downstream targets or its key regulators pRb, c-myc and cyclinD1 12.